Georgetown University Medical Center, Washington, DC - November 21, 2001 - The Center for Drug Development Science (CDDS), today announced that Howard (Hyeong Ki) Lee, MD, PhD, will join the CDDS faculty, expected to be appointed Assistant Professor of Pharmacology, effective February 1, 2002.
"Howard's excellent skills in drug development and regulatory sciences will extend our faculty's research, teaching, and consulting capabilities. Already experienced in clinical drug development (MSD Korea and Chong Kun Dang Pharmaceutical Corp., 1994 - 2000), Howard undertook postdoctoral training in CDDS's international postdoctoral fellowship program in drug development (pharmacometrics emphasis) and regulatory sciences during 2000 - 2001. These skills make him well suited to contribute to CDDS's mission of advancing clinical drug development science as an academic discipline", said Carl C. Peck, MD, Director of Center for Drug Development Science and Professor of Pharmacology and Medicine. "His medical training, expertise in epidemiology, statistics, pharmacometrics, and industrial drug development, coupled with a passion for advancing clinical pharmacology driven drug development, will hasten accomplishment of our mission. He clearly understands the tremendous opportunity ahead for CDDS, and I believe that his contributions will significantly advance the field of drug development science. Howard's capabilities add depth to the broad skills of CDDS professors Kimko, Mould, and Holford."
Howard Lee is a graduate of the Seoul National University College of Medicine, Seoul, Korea, where he received the MD (1988), MSc (1991, Epidemiology), and PhD (1997, Preventive Medicine and Epidemiology) degrees. He has a diploma in Advanced Management Program for Health Industry (1997, Sejong University, Graduate School of Public Administration, Seoul, Korea). Dr. Lee also completed internship and residency training in the Seoul National University Hospital (1988 - 1991), and is board certified in Family Medicine. During his fellowship at CDDS, Dr. Lee worked for 4 months as Guest Medical Reviewer at the Division of Cardio-Renal Products, Center for Drug Evaluation and Research, FDA.
Before joining CDDS, Howard Lee held a variety of leadership positions, including Chairman, The Korean Society for Clinical Trials (1996 - 1998) and Secretary General and Director of General Affairs, The Korean Academy of Pharmaceutical Medicine (1998 - 1999). He also served as a member of Advisory Committee of New Drug Reevaluation, Central Pharmaceutical Affairs Council, Korea Food and Drug Administration (KFDA, 1998 - 1999), and was credited with helping KFDA to modernize clinical trial regulations in Korea.
His main research interests are pharmacometrics, clinical trial outcome modeling, and regulatory science. He is also investigating how drug exposure-response relationships can be expanded to clinical settings by applying both pharmacometric and epidemiological methodologies. Dr. Lee has recently researched population pharmacokinetic and pharmacodynamic (PK/PD) modeling of an antihypertensive agent using 24-hour ambulatory blood pressure monitoring measurements, etanercept PK/PD using logistic regression analysis, post-marketing drug dosage changes of 499 FDA-approved new molecular entities during 1980-1999, and has prepared manuscripts for publication of these investigations.
Selections from more than 25 earlier publications include:
The mission of Georgetown's Center For Drug Development Science is to establish clinical drug development science as a rigorous academic discipline for advancing new scientific methodologies, to contribute to the education of scientists engaged in clinical evaluation of drugs, and to provide solutions to real-world drug development problems. For more information, visit http://cdds.georgetown.edu
Improving Drug Development Using Patient Adherence Data
in Clinical Trials, May 6-7, 2008.
Brochure (PDF)
Registration site
Advanced NONMEM workshop – March 17–19, 2008 at Mission Bay Conference Center, San Francisco, CA.
More information >
UCSF-CDDS to launch The American Course on Drug Development and
Regulatory Science- September 2007
More information >
CDDS – Pharmacometric Services is available to drug researchers
More >
Howard Lee, MD, PhD, named Director of CDDS
More >
Lewis B. Sheiner Memorial. Symposium held at CDDS in December 2006
More >
This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.